Uploaded November 2026 | Updated November 2026, 2 days ago
Figures from the OECD show that stroke is the second-largest cause of death from CVD, with one in four adults experiencing a stroke in their lifetime. It carries a high risk of long-term disability, driving substantial economic costs through care and lost productivity. What are the costs and the benefits of primary and secondary stroke prevention, and how can health leaders better address its socioeconomic impact?
Moderator:
Elly Vaughan, principal, health policy and insights, Economist Enterprise
Speakers:
Bo Norrving, chair, global policy committee, World Stroke Organisation
Cristina Masseria, vice-president, head of global market access, cardiovascular & immunology, Bristol Myers Squibb
Veronika Rybanska, director, department of analysis, Ministry of health, Slovakia
José Leal, professor of health economics, Nuffield Department of Primary Care Health Sciences, University of Oxford
Figures from the OECD show that stroke is the second-largest cause of death from CVD, with one in four adults experiencing a stroke in their lifetime. It carries a high risk of long-term disability, driving substantial economic costs through care and lost productivity. What are the costs and the benefits of primary and secondary stroke prevention, and how can health leaders better address its socioeconomic impact?
Moderator:
Elly Vaughan, principal, health policy and insights, Economist Enterprise
Speakers:
Bo Norrving, chair, global policy committee, World Stroke Organisation
Cristina Masseria, vice-president, head of global market access, cardiovascular & immunology, Bristol Myers Squibb
Veronika Rybanska, director, department of analysis, Ministry of health, Slovakia
José Leal, professor of health economics, Nuffield Department of Primary Care Health Sciences, University of Oxford










